Metronidazole PCD Pharma Franchise Company
Cafoli Lifecare offers 23 Metronidazole formulations spanning cream, dry syrup, infusion, ointment, softgel, suspension, syrup and tablets. Every batch is produced at WHO-GMP certified facilities and supplied to franchise partners with monopoly rights.
What is Metronidazole?
Metronidazole is a nitroimidazole antimicrobial active against anaerobic bacteria and protozoa. Inside these organisms it is reduced to reactive intermediates that damage microbial DNA, causing cell death. It is listed on the WHO Essential Medicines List; further detail is available on MedlinePlus.
Therapeutic Applications
Metronidazole is used for amoebiasis, giardiasis, trichomoniasis, bacterial vaginosis, dental and periodontal infections, and intra-abdominal or post-surgical anaerobic infections. Prescribers include general physicians, gastroenterologists, gynaecologists, dentists and surgeons.
Why Metronidazole is a High-Potential Molecule for Distributors
Water-borne protozoal and anaerobic infections remain widespread in India, keeping Metronidazole in year-round demand rather than making it seasonal. Its breadth of formats — paediatric suspension, adult tablets, topical preparations and hospital IV infusion — means a single molecule opens four distinct sales channels for a franchise partner.
Why Choose Cafoli Lifecare
Cafoli provides district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, attractive net rates and complete promotional inputs, with 1000+ partners already onboard across India.
References
- MedlinePlus: Metronidazole
- WHO Essential Medicines List
- PubChem: Metronidazole
Our formulations of Metronidazole find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: